Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Visani

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
World Journal of Stem Cells|September 2, 2015
Advancement in high dose therapy and autologous stem cell rescue in lymphomaAlessandro Isidori, Cristina Clissa, Federica Loscocco, et al.
Frontiers in Oncology|November 12, 2019
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid LeukemiaMarilena Ciciarello, Giulia Corradi, Federica Loscocco, et al.
Transplantation and Cellular Therapy|May 10, 2021
Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell TransplantAlessandro Isidori, Federica Loscocco, Giuseppe Visani, et al.
Journal of Leukocyte Biology|June 7, 2002
Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitorsValeria Bertagnolo, Marco Marchisio, Sabina Pierpaoli, et al.
Expert Review of Hematology|September 3, 2013
High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and futureAlessandro Isidori, Pier Paolo Piccaluga, Federica Loscocco, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for B-thalassemia majorGiuseppe Visani, Paola Picardi, Barbara Guiducci, et al.
American Journal of Hematology|October 28, 2014
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivoSilvana Anna Maria Urru, Igor Tandurella, Mario Capasso, et al.
Expert Review of Hematology|November 14, 2013
Alternative novel therapies for the treatment of elderly acute myeloid leukemia patientsAlessandro Isidori, Adriano Venditti, Luca Maurillo, et al.
Expert Review of Hematology|July 16, 2014
Conditioning regimens in acute myeloid leukemiaGiuseppe Visani, Michele Malagola, Barbara Guiducci, et al.
American Journal of Hematology|February 4, 2018
Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trialAnna Candoni, Cristina Papayannidis, Giovanni Martinelli, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
World Journal of Stem Cells|September 2, 2015
Advancement in high dose therapy and autologous stem cell rescue in lymphomaAlessandro Isidori, Cristina Clissa, Federica Loscocco, et al.
Frontiers in Oncology|November 12, 2019
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid LeukemiaMarilena Ciciarello, Giulia Corradi, Federica Loscocco, et al.
Transplantation and Cellular Therapy|May 10, 2021
Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell TransplantAlessandro Isidori, Federica Loscocco, Giuseppe Visani, et al.
Journal of Leukocyte Biology|June 7, 2002
Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitorsValeria Bertagnolo, Marco Marchisio, Sabina Pierpaoli, et al.
Expert Review of Hematology|September 3, 2013
High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and futureAlessandro Isidori, Pier Paolo Piccaluga, Federica Loscocco, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Third party cord blood transplant boosts autologous hematopoiesis in a case of persistent bone marrow aplasia after double transplant failure for B-thalassemia majorGiuseppe Visani, Paola Picardi, Barbara Guiducci, et al.
American Journal of Hematology|October 28, 2014
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivoSilvana Anna Maria Urru, Igor Tandurella, Mario Capasso, et al.
Expert Review of Hematology|November 14, 2013
Alternative novel therapies for the treatment of elderly acute myeloid leukemia patientsAlessandro Isidori, Adriano Venditti, Luca Maurillo, et al.
Expert Review of Hematology|July 16, 2014
Conditioning regimens in acute myeloid leukemiaGiuseppe Visani, Michele Malagola, Barbara Guiducci, et al.
American Journal of Hematology|February 4, 2018
Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trialAnna Candoni, Cristina Papayannidis, Giovanni Martinelli, et al.
Pageof 11